Kit for detecting mutation expression of BRAF gene V600E of colorectal cancer patient through peripheral blood circulating tumor cells

A technology for peripheral blood circulation and colorectal cancer, applied in the field of molecular biology, can solve the problems of false positives and false negatives in detection methods, and the inability of tissue samples to evaluate the real-time dynamic status of BRAF gene V600E mutations in patients, achieving good stability and reducing cell loss, the effect of avoiding edge effects

Inactive Publication Date: 2020-08-11
SHANDONG FIRST MEDICAL UNIV & SHANDONG ACADEMY OF MEDICAL SCI
View PDF0 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0008] For the detection of patients with advanced tumors or recurrent colorectal cancer in the prior art, it is impossible to obtain tissue samples in real time or repeated punctures, and thus cannot evaluate the real-time dynamic status of the BRAF gene V600E mutation in patients, and the shortcomings of existing detection methods are prone to false positives and false negatives , the present invention provides an immunofluorescence kit and detection method for BRAF gene V600E mutation expression in peripheral blood circulating tumor cells of patients with colorectal cancer, using a membrane filtration device to separate and obtain circulating tumor cells (CTCs) in peripheral blood of patients with advanced colorectal cancer , further using immunofluorescence technology to detect the expression of BRAF gene V600E mutation on CTC

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Kit for detecting mutation expression of BRAF gene V600E of colorectal cancer patient through peripheral blood circulating tumor cells
  • Kit for detecting mutation expression of BRAF gene V600E of colorectal cancer patient through peripheral blood circulating tumor cells
  • Kit for detecting mutation expression of BRAF gene V600E of colorectal cancer patient through peripheral blood circulating tumor cells

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0051] 1. Use a membrane filtration device to separate and obtain CTCs in the peripheral blood of patients with advanced or recurrent colorectal cancer whose tissue samples cannot be obtained, and determine whether CTCs exist:

[0052] Collect 5ml of fasting blood from the median vein of the elbow for 8-12 hours, dilute the peripheral blood with 45ml of diluent, and then add 3ml of 4% paraformaldehyde to fix the diluted blood sample for 10 minutes;

[0053] At fixed intervals, assemble the membrane filtration device: as attached figure 1 , figure 2 , image 3 As shown, the filtering device is composed of a filter 3, a filter membrane 7, a blood sample container 2, a waste liquid tank 5, and an iron stand 1;

[0054] Wet the filter 3 with 10ml of PBS, and then add the fixed peripheral blood sample into the blood sample container 2 of the membrane filtration device, so that it is naturally filtered by gravity, and the CTC is trapped on the filter membrane 7;

[0055] The dia...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
diameteraaaaaaaaaa
diameteraaaaaaaaaa
Login to view more

Abstract

The invention provides a kit for detecting mutation expression of a BRAF gene V600E of a colorectal cancer patient through peripheral blood circulating tumor cells, and belongs to the field of molecular biology, and concretely the kit comprises a primary antibody suspension composed of goat serum, mouse anti-CK, mouse anti-CD45 and rabbit anti-BRAF gene V600E mutation, and a secondary antibody suspension composed of a fluorescently-labeled goat anti-mouse, a fluorescently-labeled goat anti-mouse and a fluorescently-labeled goat anti-rabbit. The detection method mainly comprises the following steps: collecting peripheral blood, treating the peripheral blood, filtering and enriching the circulating tumor cells, and detecting the mutation expression condition of the BRAF gene V600E of the circulating tumor cells by an immunofluorescence method.

Description

technical field [0001] The invention provides an immunofluorescence kit and detection method for BRAF gene V600E mutation expression of peripheral blood circulating tumor cells of colorectal cancer patients and belongs to the technical field of molecular biology. Background technique [0002] Colorectal cancer (CRC) is one of the most common digestive tract malignancies in my country. According to statistics, the morbidity and mortality of CRC are at the forefront of all malignant tumors and are on the rise. However, its pathogenic factors and pathogenesis are still not completely clear. At present, it is considered to be a complex process involving multiple genes involved in the regulation, involving the abnormal activation of oncogenes (such as RAF, etc.) and the inactivation of tumor suppressor genes (such as APC, P53, etc.). Studies have shown that BRAF gene plays an important role in the pathogenesis and treatment of colorectal cancer. However, there have not been man...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): G01N33/574C12N5/09
CPCC12N5/0694C12N2509/10G01N33/57419G01N33/57446G01N33/57484G01N2333/82
Inventor 黄宁夏梅李胜李浩
Owner SHANDONG FIRST MEDICAL UNIV & SHANDONG ACADEMY OF MEDICAL SCI
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products